We are monitoring the impact of COVID-19 & Recession alarm on APAC Gamma Knife Market Get in touch with us for detailed analysis Know More

Know More

Share on

Asia Pacific Gamma Knife Market Research Report - Segmented By Disease Indication & Country(India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2022 to 2027)

Published: January, 2022
ID: 7967
Pages: 145

Asia Pacific Gamma Knife Market Size & Growth (2022 to 2027):

The Size of the Gamma Knife Market in the Asia Pacific is valued at USD 59.35 million in 2022 and is estimated to grow at a CAGR of 9.63%, to reach USD 93.99 million by 2027.

Due to the increasing incidence of cancer and obesity and the aging population, the Asia Pacific Gamma Knife market is booming. Furthermore, the rise in the number of efforts made by various government organizations, the growing number of people with neurological disorders, and the enhanced features of Gamma Knife systems are propelling the market forward. Another key growth-boosting aspect is an increasing understanding of the technology involved in the operation and the appealing advantages it offers over open surgeries.

The market for gamma knife therapy in neurological treatment is likely to rise because of its advantages over traditional surgeries. Because it is a non-invasive procedure, it provides greater safety, minor injury to surrounding tissues, and pinpoint precision when treating target cells in the brain. The market is likely to drive by increased usage of these instruments in surgery centers due to the rising prevalence of neurological diseases and the growing desire for minimally invasive treatments. The Leksell Gamma Knife Icon, which was recently invented, is in high demand, and there is a greater need for this technology to be developed.

The market's growth is hampered by strict regulatory standards, a lengthy licensing process for Gamma Knife systems, expensive implementation costs, and the scarcity of experienced professionals. Furthermore, the expense of treatment is highly significant. As a result, the majority of people cannot afford it. The tumor's severity also determines the expense of treatment. 

This research report on the APAC Gamma Knife Market has been segmented and sub-segmented into the following categories:

By Disease Indication: 

  • Brain Metastasis
  • Cancer
  • Trigeminal Neuralgia
  • AVM
  • Others

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, Asia Pacific is expected to have the most significant CAGR during the forecast period because of the rising implementation of gamma knife surgical technology, also contributing to the expansion of this area in the gamma knife market is an increase in the number of patients with cancer and brain tumors, as well as improved healthcare technologies, particularly in emerging countries.

The China gamma knife market is witnessing significant growth due to expanding population, rising disposable income, an aging population, and rising awareness levels. As a result, the Asian market attracts more new entrants than the developed world.

The Japan gamma knife market has the highest revenue share in this region. Japan is the world's second-largest market in terms of volume. Increased disease and the growing use of gamma knife tools in surgery centers contribute to its domination.

The India gamma knife market is the fastest-growing region because of the increased use of high-cost, technologically advanced products. Due to the rising approval of gamma knife treatment systems, the Asia Pacific gamma knife market is likely to reach significantly throughout the forecast period.

For example, the China Food and Drug Administration (CFDA) approved Elekta's Leksell Gamma Knife Icon radiosurgery system in 2018, allowing healthcare practitioners to deliver this advanced technology to Chinese patients.


Top companies leading in the APAC Gamma Knife Market profiled in the report are Cyber Medical Corporation Ltd., ET Medical group and American Shared Hospital Services, Masep Infini Asia Pacific, Inc., Hokai, Nordion Inc, Huiheng Medical Inc, Elekta AB, Varian Medical Systems.,

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Disease Indication                   

                                5.1.1 Brain Metastasis   

                                5.1.2 Cancer      

                                5.1.3 Trigeminal Neuralgia           

                                5.1.4 AVM (Arteriovenous Malformation)           

                                5.1.5 Others      

                                5.1.6  Y-o-Y Growth Analysis, By Disease Indication          

                                5.1.7  Market Attractiveness Analysis, By Disease Indication        

                                5.1.8  Market Share Analysis, By Disease Indication         

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                       By Disease Indication

                                6.1.4  Market Attractiveness Analysis     

                                       By Disease Indication

                                6.1.5  Market Share Analysis      

                                       By Disease Indication

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Varian Medical Systems                        

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Elekta AB                     

                8.3 Cyber Medical Corporation Ltd.                         

                8.4 Huiheng Medical Inc.                              

                8.5 Masep Infini Global, Inc.                       

                8.6 Hokai                             

                8.7 Nordion Inc.                               

                8.8 ET Medical group                     

                8.9 American Shared Hospital Services                  

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         


                a) List of Tables                

                b) List of Figures                              

  1. Asia Pacific Gamma Knife  Market By Disease Indication , From 2022 to 2027 ( USD Million )
  2. Asia Pacific Brain Metastasis Market By Region, From 2022 to 2027 ( USD Million )
  3. Asia Pacific Cancer Market By Region, From 2022 to 2027 ( USD Million )
  4. Asia Pacific Trigeminal Neuralgia Market By Region, From 2022 to 2027 ( USD Million )
  5. Asia Pacific AVM  Market By Region, From 2022 to 2027 ( USD Million )
  6. Asia Pacific Others Market By Region, From 2022 to 2027 ( USD Million )
  7. Japan Gamma Knife  Market By Disease Indication , From 2022 to 2027 ( USD Million )
  8. China Gamma Knife  Market By Disease Indication , From 2022 to 2027 ( USD Million )
  9. India Gamma Knife  Market By Disease Indication , From 2022 to 2027 ( USD Million )
  10. Australia Gamma Knife  Market By Disease Indication , From 2022 to 2027 ( USD Million )
  11. South Korea Gamma Knife  Market By Disease Indication , From 2022 to 2027 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports




pdf excel


pdf excel powerbi




What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.

Talk to our analyst and get customised report done according to your research needs


Check if you can avail any discount. Submit your details and our team will get back to you.


Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?

Find it too expensive?

Click for Request Sample